BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2378846)

  • 21. Intravitreal bevacizumab for incontinentia pigmenti.
    Shah PK; Bachu S; Narendran V; Kalpana N; David J; Srinivas CR
    J Pediatr Ophthalmol Strabismus; 2013 Oct; 50 Online():e52-4. PubMed ID: 25313552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subungual tumors in incontinentia pigmenti.
    Simmons DA; Kegel MF; Scher RK; Hines YC
    Arch Dermatol; 1986 Dec; 122(12):1431-4. PubMed ID: 3789779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macular vasculopathy and its evolution in incontinentia pigmenti.
    Goldberg MF
    Trans Am Ophthalmol Soc; 1998; 96():55-65; discussion 65-72. PubMed ID: 10360282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incontinentia pigmenti. Apropos of a case].
    Turut P; Dumont P; Piussan C; Madelain J
    Bull Soc Ophtalmol Fr; 1987 Oct; 87(10):1139-40, 1143. PubMed ID: 3449288
    [No Abstract]   [Full Text] [Related]  

  • 25. The Prevalence of Retinal Disease and Associated CNS Disease in Young Patients with Incontinentia Pigmenti.
    Danford ID; Scruggs BA; Capone A; Trese MT; Drenser KA; Thanos A; Nudleman E; Amphornphruet A; Tipsuriyaporn B; Hubbard GB; Ells A; Harper CA; Goldstein J; Calvo C; Wallace-Carrete C; Berry D; Chang E; Leishman L; Shapiro M; Blair M; Mikhail M; Shields CL; Schwendeman R; Yonekawa Y; Gupta MP; Orlin A; Prakhunhungsit S; Mukai S; Berrocal A; Hartnett ME; Campbell JP
    Ophthalmol Retina; 2022 Dec; 6(12):1113-1121. PubMed ID: 35691580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SUCCESSFUL TREATMENT OF REFRACTORY PROLIFERATIVE RETINOPATHY OF INCONTINENTIA PIGMENTI BY INTRAVITREAL RANIBIZUMAB AS ADJUNCT THERAPY IN A 4-YEAR-OLD CHILD.
    Ho M; Yip WWK; Chan VCK; Young AL
    Retin Cases Brief Rep; 2017 Fall; 11(4):352-355. PubMed ID: 27472514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early management of sight threatening retinopathy in incontinentia pigmenti.
    Michel S; Reynaud C; Daruich A; Hadj-Rabia S; Bremond-Gignac D; Bodemer C; Robert MP
    Orphanet J Rare Dis; 2020 Aug; 15(1):223. PubMed ID: 32854719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incontinentia pigmenti and Behçet's syndrome: an unusual combination.
    Menni S; Piccinno R; Biolchini A; Delle Piane RM; Bardare M
    Acta Derm Venereol; 1986; 66(4):351-4. PubMed ID: 2430411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revascularization After Intravitreal Bevacizumab and Laser Therapy of Bilateral Retinal Vascular Occlusions in Incontinentia Pigmenti (Bloch-Sulzberger Syndrome).
    Cernichiaro-Espinosa LA; Patel NA; Bauer MS; Negron CI; Fallas B; Pogrebniak A; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2019 Feb; 50(2):e33-e37. PubMed ID: 30768227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocutaneous disorders: tuberous sclerosis, incontinentia pigmenti, and hypomelanosis of Ito.
    Wiss K
    Semin Neurol; 1992 Dec; 12(4):364-73. PubMed ID: 1485046
    [No Abstract]   [Full Text] [Related]  

  • 31. Dental defects in incontinentia pigmenti: case report.
    Himelhoch DA; Scott BJ; Olsen RA
    Pediatr Dent; 1987 Sep; 9(3):236-9. PubMed ID: 3333828
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravitreal injection of ranibizumab in severe retinopathy of incontinentia pigmenti.
    Ni Y; Huang X; Ruan L; Xue K; Yu J; Peng J; Zhao P
    J AAPOS; 2018 Aug; 22(4):325-327.e3. PubMed ID: 29630932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dental disorders in incontinentia pigmenti. Apropos of a case].
    Favier-Payre A; Vincent R; Moulin G
    Actual Odontostomatol (Paris); 1987 Mar; 41(157):91-8. PubMed ID: 3475964
    [No Abstract]   [Full Text] [Related]  

  • 34. Structural Abnormalities of the Inner Macula in Incontinentia Pigmenti.
    Basilius J; Young MP; Michaelis TC; Hobbs R; Jenkins G; Hartnett ME
    JAMA Ophthalmol; 2015 Sep; 133(9):1067-72. PubMed ID: 26043102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early indirect laser photocoagulation to induce regression of retinal vascular abnormalities in incontinentia pigmenti.
    Batioglu F; Ozmert E
    Acta Ophthalmol; 2010 Mar; 88(2):267-8. PubMed ID: 18983617
    [No Abstract]   [Full Text] [Related]  

  • 36. VARIABLE EXPRESSION OF RETINOPATHY IN A PEDIGREE OF PATIENTS WITH INCONTINENTIA PIGMENTI.
    Chen CJ; Han IC; Goldberg MF
    Retina; 2015 Dec; 35(12):2627-32. PubMed ID: 26035514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of fluorescein angiography in incontinentia pigmenti: a case report.
    Tzu JH; Murdock J; Parke DW; Warman R; Hess DJ; Berrocal AM
    Ophthalmic Surg Lasers Imaging Retina; 2013; 44(1):91-3. PubMed ID: 23410815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The blinding mechanisms of incontinentia pigmenti.
    Goldberg MF
    Trans Am Ophthalmol Soc; 1994; 92():167-76; discussion 176-9. PubMed ID: 7886862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Incontinentia pigmenti. Apropos of a new case].
    Aubin F; Blanc D; Planchat A; Quencez E; Agache P
    Arch Fr Pediatr; 1987; 44(7):509-11. PubMed ID: 3426373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral cerebrovascular accidents in incontinentia pigmenti.
    Fiorillo L; Sinclair DB; O'Byrne ML; Krol AL
    Pediatr Neurol; 2003 Jul; 29(1):66-8. PubMed ID: 13679126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.